ArticleFrontiers in immunology2023

IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy.

Qisheng Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.